LOCKSTOWN PRACTICE — All Prescriptions & Medications — Page 5
Practice Code: M91021 | WILLENHALL, WV13 2DR
Showing results 201-250 of 604
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Co-dydramol (Dihydrocodeine/paracetamol) | 132 | 18.8K | £836 | -26.5% ▼ |
| Brinzolamide | 132 | 1,080 | £818 | +1.6% vs avg |
| Dorzolamide and timolol | 129 | 5,430 | £2.8K | -9.9% ▼ |
| 128 | 2,245 | £989 | -48.7% ▼ | |
| Pantoprazole | 127 | 5,460 | £250 | -53.8% ▼ |
| Amisulpride | 125 | 4,212 | £1.8K | +77.8% ▲ |
| Vortioxetine | 125 | 4,375 | £4.1K | +80.1% ▲ |
| Procyclidine hydrochloride | 124 | 9,267 | £1.1K | -12.4% ▼ |
| Ivabradine | 123 | 6,544 | £965 | +29.4% ▲ |
| Metoclopramide hydrochloride | 121 | 7,657 | £263 | +46.0% ▲ |
| Donepezil hydrochloride | 121 | 3,664 | £1.4K | -60.8% ▼ |
| 121 | 121 | £540 | +135.9% ▲ | |
| Trazodone hydrochloride | 120 | 3,164 | £159 | -41.3% ▼ |
| Famotidine | 118 | 4,506 | £2.4K | -75.8% ▼ |
| Bumetanide | 116 | 7,280 | £717 | -57.4% ▼ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 115 | 372.0K | £10.9K | +333.0% ▲ |
| Cefalexin | 114 | 12.1K | £464 | -2.0% ▼ |
| Nortriptyline | 113 | 6,786 | £1.3K | -22.3% ▼ |
| Ranolazine | 112 | 7,640 | £1.4K | -34.1% ▼ |
| Fluticasone furoate/vilanterol | 112 | 131 | £3.0K | -27.7% ▼ |
| Progesterone | 110 | 6,286 | £1.4K | -73.7% ▼ |
| Chlorphenamine maleate | 109 | 9,310 | £257 | -1.2% vs avg |
| Zolpidem tartrate | 108 | 3,339 | £141 | +19.9% ▲ |
| Benzydamine hydrochloride | 108 | 16.5K | £385 | +39.6% ▲ |
| Other individually formulated bought in preparations | 108 | 2,500 | £1.3K | +230.6% ▲ |
| Oxycodone hydrochloride | 107 | 11.4K | £1.5K | -58.2% ▼ |
| Hydrocortisone | 107 | 8,776 | £2.1K | +26.7% ▲ |
| Hydroxychloroquine sulfate | 107 | 5,102 | £232 | -44.7% ▼ |
| Bimatoprost | 107 | 2,325 | £1.3K | -28.0% ▼ |
| Sodium bicarbonate | 106 | 12.2K | £546 | +14.7% ▲ |
| Alfacalcidol | 106 | 3,510 | £591 | -14.3% ▼ |
| Powder extensively hydrolysed formula (0913101) | 105 | 227.6K | £6.3K | +45.7% ▲ |
| Etoricoxib | 105 | 2,457 | £593 | +30.3% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 104 | 10.1K | £808 | -54.0% ▼ |
| Betamethasone esters | 104 | 4,300 | £773 | +72.4% ▲ |
| Canagliflozin | 103 | 3,882 | £4.8K | -28.3% ▼ |
| Nebivolol | 102 | 3,654 | £2.3K | -3.8% ▼ |
| Ropinirole hydrochloride | 102 | 4,963 | £3.1K | -4.0% ▼ |
| Dulaglutide | 102 | 416 | £7.6K | -11.0% ▼ |
| Tamoxifen citrate | 102 | 3,348 | £295 | +23.9% ▲ |
| Ketoconazole | 101 | 13.4K | £2.1K | +2.9% ▲ |
| Dosulepin hydrochloride | 100 | 3,728 | £566 | +76.7% ▲ |
| 99 | 3,741 | £4.3K | +166.7% ▲ | |
| Nystatin | 96 | 2,940 | £169 | -4.8% ▼ |
| Fluticasone furoate | 96 | 109 | £668 | -50.4% ▼ |
| Clobetasol propionate | 95 | 7,165 | £573 | -30.4% ▼ |
| 94 | 5,320 | £23.0K | +107.9% ▲ | |
| Umeclidinium bromide | 93 | 115 | £3.0K | +50.9% ▲ |
| Olanzapine | 93 | 4,067 | £421 | -74.9% ▼ |
| Biphasic isophane insulin | 93 | 763 | £3.3K | -16.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.